{
  "approved_at_utc": null,
  "subreddit": "stocks",
  "selftext": "**Summary:**\n\nFounded in 2013, Lucira had already developed a single-use kit to diagnose influenza when it shifted gears to focus on SARS-CoV-2 detection in the COVID-19 pandemic. In November, the company won emergency use authorization (EUA) from the U.S. FDA for its [COVID-19 All-in-One Test Kit](https://cdn-a.william-reed.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/article/2020/11/18/fda-authorises-first-covid-19-home-self-testing-kit/11954738-3-eng-GB/FDA-authorises-first-COVID-19-home-self-testing-kit.jpg), making it the first prescription molecular diagnostic test for the SARS-Cov-2 virus that can be performed from start to finish in the comfort of one’s home.\n\n\n**Technicals**\n\n* After winning emergency use authorisation in the FDA, the company is expecting billions of orders in the U.S, Europe & Asia.\n\n* The [Covid test kids](https://cdn-a.william-reed.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/article/2020/11/18/fda-authorises-first-covid-19-home-self-testing-kit/11954738-3-eng-GB/FDA-authorises-first-COVID-19-home-self-testing-kit.jpg) are one use only so expect a continious stream of these. The company has also developed it to work on all mutations of the Corona virus strain so as more mutations come up, expect more demand to rise.\n\nThis stock is cheap at the moment but expect it to moon soon.",
  "author_fullname": "t2_hi7fj",
  "saved": false,
  "mod_reason_title": null,
  "gilded": 0,
  "clicked": false,
  "title": "Lucira Health Inc (LHDX) - Home Covid test kit developer IPO",
  "link_flair_richtext": [],
  "subreddit_name_prefixed": "r/stocks",
  "hidden": false,
  "pwls": 6,
  "link_flair_css_class": "tickernews",
  "downs": 0,
  "top_awarded_type": null,
  "hide_score": false,
  "name": "t3_lfj4ke",
  "quarantine": false,
  "link_flair_text_color": "dark",
  "upvote_ratio": 0.95,
  "author_flair_background_color": null,
  "subreddit_type": "public",
  "ups": 42,
  "total_awards_received": 1,
  "media_embed": {},
  "author_flair_template_id": null,
  "is_original_content": false,
  "user_reports": [],
  "secure_media": null,
  "is_reddit_media_domain": false,
  "is_meta": false,
  "category": null,
  "secure_media_embed": {},
  "link_flair_text": "Company News",
  "can_mod_post": false,
  "score": 42,
  "approved_by": null,
  "author_premium": false,
  "thumbnail": "",
  "edited": false,
  "author_flair_css_class": null,
  "author_flair_richtext": [],
  "gildings": {
    "gid_1": 1
  },
  "content_categories": null,
  "is_self": true,
  "mod_note": null,
  "created": 1612840064,
  "link_flair_type": "text",
  "wls": 6,
  "removed_by_category": null,
  "banned_by": null,
  "author_flair_type": "text",
  "domain": "self.stocks",
  "allow_live_comments": false,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p><strong>Summary:</strong></p>\n\n<p>Founded in 2013, Lucira had already developed a single-use kit to diagnose influenza when it shifted gears to focus on SARS-CoV-2 detection in the COVID-19 pandemic. In November, the company won emergency use authorization (EUA) from the U.S. FDA for its <a href=\"https://cdn-a.william-reed.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/article/2020/11/18/fda-authorises-first-covid-19-home-self-testing-kit/11954738-3-eng-GB/FDA-authorises-first-COVID-19-home-self-testing-kit.jpg\">COVID-19 All-in-One Test Kit</a>, making it the first prescription molecular diagnostic test for the SARS-Cov-2 virus that can be performed from start to finish in the comfort of one’s home.</p>\n\n<p><strong>Technicals</strong></p>\n\n<ul>\n<li><p>After winning emergency use authorisation in the FDA, the company is expecting billions of orders in the U.S, Europe &amp; Asia.</p></li>\n<li><p>The <a href=\"https://cdn-a.william-reed.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/article/2020/11/18/fda-authorises-first-covid-19-home-self-testing-kit/11954738-3-eng-GB/FDA-authorises-first-COVID-19-home-self-testing-kit.jpg\">Covid test kids</a> are one use only so expect a continious stream of these. The company has also developed it to work on all mutations of the Corona virus strain so as more mutations come up, expect more demand to rise.</p></li>\n</ul>\n\n<p>This stock is cheap at the moment but expect it to moon soon.</p>\n</div><!-- SC_ON -->",
  "likes": null,
  "suggested_sort": null,
  "banned_at_utc": null,
  "view_count": null,
  "archived": false,
  "no_follow": false,
  "is_crosspostable": false,
  "pinned": false,
  "over_18": false,
  "awarders": [],
  "media_only": false,
  "link_flair_template_id": "5a4c814a-65e6-11e5-b65e-122ab0778f8b",
  "can_gild": false,
  "spoiler": false,
  "locked": false,
  "author_flair_text": null,
  "treatment_tags": [],
  "visited": false,
  "removed_by": null,
  "num_reports": null,
  "distinguished": null,
  "subreddit_id": "t5_2qjfk",
  "mod_reason_by": null,
  "removal_reason": null,
  "link_flair_background_color": "#f9cc80",
  "id": "lfj4ke",
  "is_robot_indexable": true,
  "report_reasons": null,
  "author": "thef1guy",
  "discussion_type": null,
  "num_comments": 9,
  "send_replies": true,
  "whitelist_status": "all_ads",
  "contest_mode": false,
  "mod_reports": [],
  "author_patreon_flair": false,
  "author_flair_text_color": null,
  "permalink": "/r/stocks/comments/lfj4ke/lucira_health_inc_lhdx_home_covid_test_kit/",
  "parent_whitelist_status": "all_ads",
  "stickied": false,
  "url": "https://www.reddit.com/r/stocks/comments/lfj4ke/lucira_health_inc_lhdx_home_covid_test_kit/",
  "subreddit_subscribers": 2157216,
  "created_utc": 1612842628,
  "num_crossposts": 0,
  "media": null,
  "is_video": false,
  "original_created_utc": 1612811264,
  "the_new_excerpt": "Summary:\n\nFounded in 2013, Lucira had already developed a single-use kit to diagnose\ninfluenza when it shifted gears to focus on SARS-CoV-2 detection in the COVID-19\npandemic. In November, the company won emergency use authorization (EUA) from\nthe U.S. FDA for its COVID-19 All-in-One Test…",
  "localize": [
    {
      "locale": "zh",
      "the_new_excerpt": "小结。\n\n成立于2013年的Lucira已经开发出了诊断的一次性试剂盒。\n在COVID-19中转而专注于SARS-CoV-2的检测时，该公司就开始了对流感的研究。\n疫情。11月，该公司获得了美国政府的紧急使用授权（EUA）。\n美国FDA对其COVID-19多合一检测仪的...",
      "title": "Lucira Health Inc(LHDX)--家用Covid检测试剂盒开发商IPO。"
    },
    {
      "locale": "zh-Hant",
      "the_new_excerpt": "小結。\n\n成立於2013年的Lucira已經開發出了診斷的一次性試劑盒。\n在COVID-19中轉而專注於SARS-CoV-2的檢測時，該公司就開始了對流感的研究。\n疫情。11月，該公司獲得了美國政府的緊急使用授權（EUA）。\n美國FDA對其COVID-19多合一檢測儀的...",
      "title": "Lucira Health Inc(LHDX)--家用Covid檢測試劑盒開發商IPO。"
    }
  ]
}